First Things First

In an industry like ours, doing things in the right order matters.  It does not matter of you are working in the lab, biz dev or the front office.  When you forget to put first things first you might not get the outcome you expect…or need.

At AZBio we have been investing our time in research.  For us that means getting out of the office and into the  community to talk to Members, create opportunities to connect and to listen to what they have to say.  Whether we are are in one-on-one visits to Members and their companies, meetings at the GPEC, The Desert Angels or BCLSA or hanging out with the AZBio Gang at Beer and Bio, we’ve been asking questions and gathering data on what you, our members want and need.   So far this research has led to some new developments and there are a lot more coming,  Here are FIVE important things you said…Continue reading

AZBio News – April and May 2011

Green and lean: Secreting bacteria eliminate cost  barriers for renewable biofuel production

Kinetic Muscles, Inc. Celebrates 10 year anniversary

Yulex names Jim Mitchell COO by Angela Gonzales, Phoenix Business Journal

Laura Gonzalez selected for Phoenix Business Journal’s ‘Forty Under 40’ honors

ISO 13485 Certification Achieved by Regenesis Biomedical

Dr. David Eberhard joins Flagship as Chief Medical Pathologist

University of Minnesota licenses multiplexing software to Flagship Biosciences

Deadline for NCI SBIR and STTR 2011 Omnibus Solicitation proposals is August 5, 2011

Small Business Innovation ResearchThe National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, one of the largest sources of early-stage technology financing in the United States, have several funding opportunities available to small businesses and research institutions.  Below are details for the funding opportunities that have upcoming deadlines:

The 2011 Omnibus Solicitation is an investigator-initiated grant funding opportunity that enables small businesses to apply for funding across a wide range of cancer related topic areas. U.S. small businesses with the research capabilities and technological expertise described in the Omnibus Solicitation are encouraged to submit investigator-initiated SBIR & STTR grant applications for the identified topics. The next deadline for receipt of NCI SBIR & STTR 2011 Omnibus Solicitation proposals is August 5, 2011.Continue reading

The Biotechnology World is Gathering

BIO 2011 is just around the corner!  June 27-30, 2011 in Washington, DC.

The Annual BIO International Convention is the world’s largest biotechnology gathering. Over 15,000 biotechnology, life science and industry professionals from around the world will gather to highlight the future of biotechnology at the BIO 2011 Annual International Convention in Washington D.C. from June 27 – 30, 2011.Continue reading

Who is Your Hero?

"Marie Curie as portrayed by Susan Marie Frontczak"

When I was a young girl, Marie Curie was one of my heroes.  There was something about the story of a young girl who was fascinated with science and math and who went on to change the world that captured my imagination and the imagination of millions of other young people like me over the years.  She was a Healthcare Hero!Continue reading

Special SBIR online class creates opportunity for Faculty and Students

Students and Faculty on the biosciences – did you know that the same federal agencies (like DOD, NIH and NSF) that funded your initial research may provide you with grants of up to $100,000 (phase 1) and $1 million (phase 2) to commercialize that very same research under the $2.5 billion federal SBIR program awarded annually. The federal government desperately needs entrepreneurial researchers to create jobs over the next ten years to solve the country’s economic problems, and will support those researchers that show they can do it with SBIR funding (and other new major research commercialization programs now under consideration by the federal government). Researchers who can commercialize research are in great demand.

Are they looking for you?Continue reading